goserelin acetate
PolandDrugs containing this active substance
-
In men, it is used to treat prostate cancer, whereas in women, it is used to treat breast cancer, endometriosis, benign uterine tumors (fibroids), to thin the uterine lining before surgery, or as an adjunct in the treatment of infertility.
Form: implant in ampoule-syringe
Active substance Dosage goserelin acetate 4.1 mg ATC: L02AE03
Manufacturer: AMW GmbH Arzneimittelwerk Warngau
-
In men, it is used to treat prostate cancer, whereas in women, it is used to treat endometriosis and uterine fibroids.
Form: implant in ampoule-syringe
Active substance Dosage goserelin acetate 12.5 mg ATC: L02AE03
Manufacturer: AMW GmbH Arzneimittelwerk Warngau
-
The medicine is used in the treatment of prostate cancer. It works by reducing the amount of testosterone in the body.
Form: implant in ampoule-syringe
Active substance Dosage goserelin acetate 12.5 mg ATC: L02AE03
Manufacturer: AMW GmbH Arzneimittelwerk Warngau Merckle GmbH
-
In men, it is used for the treatment of prostate cancer. In women, the medicine is intended for the treatment of breast cancer, endometriosis, benign uterine growths (fibroids), reduction of the thickness of the uterine lining before surgery, and in the treatment of infertility.
Form: implant, subcutaneous
Active substance Dosage goserelin acetate 3.6 mg ATC: L02AE03
Manufacturer: AstraZeneca AB
-
The medicine is used to treat prostate cancer that responds to hormonal therapy.
Form: implant, subcutaneous
Active substance Dosage goserelin acetate 10.8 mg ATC: L02AE03
Manufacturer: AstraZeneca AB